H. Erlich et al., ANALYSIS OF HLA CLASS-II POLYMORPHISM USING POLYMERASE CHAIN-REACTION, Archives of pathology and laboratory medicine, 117(5), 1993, pp. 482-485
Citations number
29
Categorie Soggetti
Pathology,"Medical Laboratory Technology","Medicine, Research & Experimental
A simple, rapid, and precise method of typing HLA class II polymorphis
m would be valuable in the areas of disease susceptibility, tissue tra
nsplantation, individual identification, and anthropological genetics.
Herein, we describe a method of analyzing class II sequence polymorph
ism based on polymerase chain reaction (PCR) amplification and hybridi
zation with oligonucleotide probes. Many more DNA-defined alleles at t
he class II loci have been identified than can be distinguished by con
ventional serologic typing. Consequently, matching transplant donors a
nd recipients by PCR/oligonucleotide typing should reduce graft reject
ion and graft-vs-host disease. Also, the ability to identify alleles c
onferring genetic predisposition to specific diseases (eg, insulin-dep
endent diabetes mellitus) is significantly enhanced by distinguishing
the many alleles or ''subtypes'' within a serologic type (eg, DR4). On
e valuable property of sequence-based HLA typing strategies, like olig
onucleotide probe hybridization, is that they reveal how and where two
alleles differ, not simply that they can be operationally distinguish
ed. The nature and location of HLA polymorphisms appears to be critica
l in disease association studies and are important in tissue typing fo
r transplantation. New alleles at the DRB1, DPB1, and DQB1 loci are li
kely to be identified as this technology is applied to more and more s
amples, particularly in nonwhite ethnic groups. A new allele is uncove
red as an unusual pattern of probe binding and then confirmed by seque
ncing. This pattern is observed because class II polymorphism is local
ized to specific regions and virtually all ''new'' alleles represent '
'shuffled'' combinations of polymorphic sequences found in previously
known alleles. Since these polymorphisms are in the region of probe bi
nding, these new alleles can be detected without increasing the probe
panel. Obviously, any new allele with a new polymorphic sequence in a
region for which typing probes are not available would not be revealed
by oligonucleotide typing. With the PCR primers and probes described
here, 7 DQalpha1 alleles, 15 DQbeta1 alleles, 18 DPB1 alleles, and 32
DRB1 alleles are distinguished. Additional primers and/or probes can,
of course, increase the allelic discrimination of PCR/oligonucleotide
probe typing. These horseradish peroxidase-labeled oligonucleotide pro
bes are stable (>2 years when stored at 4-degrees-C) and the typing sy
stem is simple and robust. Although this dot blot/oligonucleotide hybr
idization procedure is a powerful and precise method of HLA class II t
yping, the complexity of the procedure increases as the number of prob
es required for analysis increases. The reverse dot blot method, based
on an array of immobilized probes, allows the typing of individual sa
mples in one single hybridization reaction. In this approach, a panel
of unlabeled oligonucleotides are immobilized to a nylon membrane. The
PCR product is labeled during the amplification reaction by using bio
tinylated primers and hybridized to the membrane. The presence of boun
d PCR product specifically hybridized to a given probe is detected usi
ng a streptavidin-horseradish-peroxidase conjugate and either chromoge
nic or chemoluminescent substrates. This method, which has also been a
pplied to the detection of beta-thalassemia and cystic fibrosis mutati
ons, offers the simplest and most rapid approach to the HLA typing of
clinical samples.